Application of a synthetic serine protease inhibitor in the treatment of DIC.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004195:Disease Models, Animal; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D005340:Fibrinogen / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D016670:Gabexate; D006146:Guanidines / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D011480:Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013917:Thrombin / Q000378:metabolism; D013927:Thrombosis / Q000188:drug therapy
D006146:Guanidines; D011480:Protease Inhibitors; D016670:Gabexate; D005340:Fibrinogen; D013917:Thrombin; D005341:Fibrinolysin